000 01428 a2200409 4500
005 20250514064021.0
264 0 _c20031211
008 200312s 0 0 eng d
022 _a8756-3282
024 7 _a10.1016/s8756-3282(03)00030-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan Etten, E
245 0 0 _aCombination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone.
_h[electronic resource]
260 _bBone
_cApr 2003
300 _a397-404 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAnimals
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aCalcium
_xblood
650 0 4 _aCytokines
_xdrug effects
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFemur
_xdrug effects
650 0 4 _aMice
650 0 4 _aOsteocalcin
_xblood
650 0 4 _aPamidronate
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aVitamin D
_xanalogs & derivatives
700 1 _aBranisteanu, D D
700 1 _aOverbergh, L
700 1 _aBouillon, R
700 1 _aVerstuyf, A
700 1 _aMathieu, C
773 0 _tBone
_gvol. 32
_gno. 4
_gp. 397-404
856 4 0 _uhttps://doi.org/10.1016/s8756-3282(03)00030-9
_zAvailable from publisher's website
999 _c12481667
_d12481667